Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

Presentation of MyPEAK-1 Data and the American Heart Association Scientific Sessions Showed Consistent, Deeper, and Durable ...

Emerging research highlights the transformative potential of m6A RNA modification in the diagnosis and treatment of cardiovascular diseases (CVDs). As the most abundant internal modification of ...

Just in time for the festive season, a powerful new force in global luxury retail has arrived. GlamSteals.com, founded by Australian entrepreneur Sasha Ahuja, officially makes its worldwide debut ?

More than 60,000 students from 100+ National Heritage Academies schools across nine states wrote handwritten thank you notes ...

Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 in Friedreich Ataxia (FA) and DT-168 in Fuchs Endothelial ...

Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

This article explores how epigenetic mechanisms control gene expression, how their disruption drives cancer and how targeting ...

New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and ...

Emerging opportunities in the STAT Inhibitors market lie in targeting dysregulated STAT pathways, particularly STAT3 and STAT5, for cancers and inflammatory conditions. Novel drugs like Tvardi's ...